Mr Liang Chao (right) together with SCM representatives attend the third Oxford symposium on aptamers


梁超同學 (右) 與出席「第三屆適配子大會」的中醫藥學院代表合照

Mr Liu Jin attends the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases in Spain


劉進同學出席在西班牙舉行的「2016年世界骨質疏鬆,骨關節炎與骨骼肌肉系統疾病大會」

Date: 29 Apr 2016 (Friday)

Archive

SCM PhD students win recognition for outstanding research in bone and joint diseases

中醫藥學院兩博士研究生優秀論文再獲殊榮

Mr Liang Chao and Mr Liu Jin, PhD students of the School of Chinese Medicine (SCM) won a travel award and a prize from the ESCEO-AgNovos Healthcare Young Investigator Awards respectively in recognition of their outstanding researches on bone and joint diseases. They both gained sponsorship to present their work at international conferences in Europe.

Mr Liang Chao won a travel award to attend the third Oxford symposium on aptamers, Aptamers 2016, which was held from 4 to 5 April 2016 at the University of Oxford, UK, at which he presented his work entitled “Oligopeptide aptamer-modified chalcone derivative specifically targets Smurf1 in osteoblasts and promotes bone formation”. The symposium brought together academic and industrial aptamer researchers to address therapeutic, diagnostic, analytical as well as basic research applications of aptamers.

Mr Liu Jin was granted a sponsorship by the ESCEO-AgNovos Healthcare Young Investigator Awards to attend the World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases held in Malaga, Spain from 14 to 17 April, at which he made a poster presentation about his award-winning research paper entitled “miR-214-3p targets TRAF3 to promote osteoclastic bone resorption during the development of postmenopausal osteoporosis”. Co-organised by the International Osteoporosis Foundation and the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) for healthcare professionals, researchers and young scientists, the Congress is the largest educational platform and most vibrant clinical research forum in the field of osteoporosis, osteoarthritis and musculoskeletal diseases in Europe.

中醫藥學院博士研究生梁超和劉進在骨與關節疾病研究方面的優秀表現再次得到肯定,兩人分別獲頒遊歷獎和青年學者獎,獲資助出席於英國和西班牙舉行的國際研討會,並於會上發表他們的研究項目。

梁超同學獲頒發遊歷獎,出席於4月4至5日在英國牛津大學舉行的「第三屆適配子大會」,於會上發表題為「寡肽適配子修飾的查爾酮衍生物特異性靶向成骨細胞中的Smurf1並促進骨形成」的演說。該會議旨在召集適配子學術研究和工業生產人員,共同探討適配子在疾病治療、診斷,以及化學分析中的應用。

劉進同學的傑出論文《微小核酸miR-214-3p靶向TRAF3促進破骨細胞骨吸收並調控絕經後骨質疏鬆》,獲頒發「ESCEO-AgNovos Healthcare青年學者獎」,資助他出席於4月14至17日在西班牙馬拉加舉行的「2016年世界骨質疏鬆,骨關節炎與骨骼肌肉系統疾病大會」,於會上以論文海報形式展示他的研究結果。大會由「國際骨質疏鬆基金會」與「歐洲骨質疏鬆和骨關節炎臨床與經濟資訊學會」共同舉辦,專為醫療保健專家、研究人員及年青科研人員而設,是歐洲最大規模的有關骨關節肌肉疾病的學術和臨床研究的交流平台。